Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux
To access this article, please choose from the options below
PII: S0021-9150(02)00037-0
© 2002 Elsevier Science Ireland Ltd. All rights reserved.
